🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07663097
Starting soon Observational

Preoperative Anxiety and Surgical Fear in Holmium Laser Enucleation of the Prostate and Transurethral Resection of the Prostate Patients With Benign Prostatic Hyperplasia

NCT07663097 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2026-06-14
Last updated
2026-06-26

Condition(s) studied

Benign Prostatic Hyperplasia

Investigational drug(s) / intervention(s)

Holmium Laser Enucleation of the Prostate (HoLEP)Transurethral Resection of the Prostate (TURP)

Holmium Laser Enucleation of the Prostate (HoLEP): Standard HoLEP procedure for treatment of benign prostatic hyperplasia.

Transurethral Resection of the Prostate (TURP): Standard TURP procedure for treatment of benign prostatic hyperplasia.

Study summary

Benign prostatic hyperplasia (BPH) is a common condition in older men and may cause bothersome lower urinary tract symptoms that can negatively affect quality of life. Surgical treatment with Holmium Laser Enucleation of the Prostate (HoLEP) or Transurethral Resection of the Prostate (TURP) is often recommended when medical therapy is insufficient.

This prospective observational study aims to evaluate whether preoperative anxiety, depression, and surgical fear influence postoperative functional outcomes, urinary continence, erectile function, and patient satisfaction in patients undergoing HoLEP or TURP for BPH. Participants will complete validated psychological and functional questionnaires before surgery and during postoperative follow-up visits at 1 and 3 months. The study will also assess changes in psychological status after surgery and compare outcomes between HoLEP and TURP patients.

The findings may help improve preoperative patient counseling and identify patients who could benefit from additional psychological support before surgery.

Eligibility

Sex
MALE
Min age
50 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Male patients aged 50 years or older * Diagnosis of benign prostatic hyperplasia (BPH) * Scheduled to undergo HoLEP or TURP * Ability to understand and complete study questionnaires * Provided written informed consent Exclusion Criteria: * History of severe psychiatric disorder * Active psychiatric treatment * Neurogenic bladder or neurologic voiding dysfunction * Diagnosis of prostate cancer * Previous prostate surgery * Inability to comply with study procedures or follow-up visits

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Hitit university Çorum Çorum

More Hitit University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07663097 on ClinicalTrials.gov ↗ ← All trials in Turkey